CRO's Cross Over NOW

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001
Volume 0
Issue 0

The digital revolution is knocking at the doors of the clinical research industry, and CROs are increasingly, if reluctantly, letting it in. Although the biotech industry revels in the promise of wireless solutions, Internet applications, and genomic discoveries, CROs have largely shunned opportunities for technological improvements and remain insulated from such advances in other health sectors.

Recent Videos
John Arena
John Arena
James Foster
John Arena
James Foster
Navigating an Uncertain Regulatory Landscape
Related Content